Recent studies revealed that BRAF V600E-mutated CRC cells displayed greater reliance on ENO2, thereby regulating proliferation, migration, and drug resistance in CRC cells by activating PI3K/Akt and MAPK pathways [29]. This evidence concerns the gene BRAF and colorectal carcinoma.